James Joseph O'Connor - 21 Apr 2026 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Reporting relationship: Chief Business Officer and GC
Issuer ticker: NERV
Reported as of: 21 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Apr 2026, 16:55:18 UTC
Source filing: View source filing
Reporting owner signature: /s/ Fred Ahlholm, Attorney-in-Fact

Key filing fact

James Joseph O'Connor filed Form 4 for Minerva Neurosciences, Inc. (NERV) on 22 Apr 2026.

Key facts

This page summarizes James Joseph O'Connor's Form 4 filing for Minerva Neurosciences, Inc. (NERV).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Apr 2026, 16:55.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002129698 Primary reporting owner

O'Connor James Joseph

Relationship: Chief Business Officer and GC
Address: C/O MINERVA NEUROSCIENCES, INC., 1500 DISTRICT AVENUE, BURLINGTON
Signature: /s/ Fred Ahlholm, Attorney-in-Fact
Signature date: 22 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NERV transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +350,800
Change %
Price: $0.000000^*
Shares after: 350,800
Date: 21 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 350,800
Exercise price: $6.97
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests 25% on April 21, 2027 and then in equal quarterly installments over 3 years thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .